English
简体中文
Total: £ 56.28
Published Date: 2024-09-13 | Pages: 143 | Tables: 258 | Pharma & Healthcare
The global market for Anti Obesity Drugs was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Anti Obesity Drugs, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Anti Obesity Drugs by region & country, by Type, and by Application.
The Anti Obesity Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti Obesity Drugs.
Market Segmentation
By Company
Pfizer
Merck
Roche
GlaxoSmithKline
AstraZeneca
Boehringer Ingelheim
Novo Nordisk
Eisai
Norgine
Arena Pharmaceuticals
Orexigen Therapeutics
Vivus
Alizyme
Rhythm Pharmaceuticals
Shionogi
Zafgan
Segment by Type:
Oral Medicine
Diet Patch
Other
Segment by Application
Men
Women
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Anti Obesity Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Anti Obesity Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Anti Obesity Drugs in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Market Overview
1.1 Anti Obesity Drugs Product Introduction
1.2 Global Anti Obesity Drugs Market Size Forecast
1.2.1 Global Anti Obesity Drugs Sales Value (2019-2030)
1.2.2 Global Anti Obesity Drugs Sales Volume (2019-2030)
1.2.3 Global Anti Obesity Drugs Sales Price (2019-2030)
1.3 Anti Obesity Drugs Market Trends & Drivers
1.3.1 Anti Obesity Drugs Industry Trends
1.3.2 Anti Obesity Drugs Market Drivers & Opportunity
1.3.3 Anti Obesity Drugs Market Challenges
1.3.4 Anti Obesity Drugs Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Anti Obesity Drugs Players Revenue Ranking (2023)
2.2 Global Anti Obesity Drugs Revenue by Company (2019-2024)
2.3 Global Anti Obesity Drugs Players Sales Volume Ranking (2023)
2.4 Global Anti Obesity Drugs Sales Volume by Company Players (2019-2024)
2.5 Global Anti Obesity Drugs Average Price by Company (2019-2024)
2.6 Key Manufacturers Anti Obesity Drugs Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Anti Obesity Drugs Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Anti Obesity Drugs
2.9 Anti Obesity Drugs Market Competitive Analysis
2.9.1 Anti Obesity Drugs Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Anti Obesity Drugs Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti Obesity Drugs as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Oral Medicine
3.1.2 Diet Patch
3.1.3 Other
3.2 Global Anti Obesity Drugs Sales Value by Type
3.2.1 Global Anti Obesity Drugs Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Anti Obesity Drugs Sales Value, by Type (2019-2030)
3.2.3 Global Anti Obesity Drugs Sales Value, by Type (%) (2019-2030)
3.3 Global Anti Obesity Drugs Sales Volume by Type
3.3.1 Global Anti Obesity Drugs Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Anti Obesity Drugs Sales Volume, by Type (2019-2030)
3.3.3 Global Anti Obesity Drugs Sales Volume, by Type (%) (2019-2030)
3.4 Global Anti Obesity Drugs Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Men
4.1.2 Women
4.2 Global Anti Obesity Drugs Sales Value by Application
4.2.1 Global Anti Obesity Drugs Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Anti Obesity Drugs Sales Value, by Application (2019-2030)
4.2.3 Global Anti Obesity Drugs Sales Value, by Application (%) (2019-2030)
4.3 Global Anti Obesity Drugs Sales Volume by Application
4.3.1 Global Anti Obesity Drugs Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Anti Obesity Drugs Sales Volume, by Application (2019-2030)
4.3.3 Global Anti Obesity Drugs Sales Volume, by Application (%) (2019-2030)
4.4 Global Anti Obesity Drugs Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Anti Obesity Drugs Sales Value by Region
5.1.1 Global Anti Obesity Drugs Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Anti Obesity Drugs Sales Value by Region (2019-2024)
5.1.3 Global Anti Obesity Drugs Sales Value by Region (2025-2030)
5.1.4 Global Anti Obesity Drugs Sales Value by Region (%), (2019-2030)
5.2 Global Anti Obesity Drugs Sales Volume by Region
5.2.1 Global Anti Obesity Drugs Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Anti Obesity Drugs Sales Volume by Region (2019-2024)
5.2.3 Global Anti Obesity Drugs Sales Volume by Region (2025-2030)
5.2.4 Global Anti Obesity Drugs Sales Volume by Region (%), (2019-2030)
5.3 Global Anti Obesity Drugs Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Anti Obesity Drugs Sales Value, 2019-2030
5.4.2 North America Anti Obesity Drugs Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Anti Obesity Drugs Sales Value, 2019-2030
5.5.2 Europe Anti Obesity Drugs Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Anti Obesity Drugs Sales Value, 2019-2030
5.6.2 Asia Pacific Anti Obesity Drugs Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Anti Obesity Drugs Sales Value, 2019-2030
5.7.2 South America Anti Obesity Drugs Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Anti Obesity Drugs Sales Value, 2019-2030
5.8.2 Middle East & Africa Anti Obesity Drugs Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Anti Obesity Drugs Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Anti Obesity Drugs Sales Value
6.2.1 Key Countries/Regions Anti Obesity Drugs Sales Value, 2019-2030
6.2.2 Key Countries/Regions Anti Obesity Drugs Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Anti Obesity Drugs Sales Value, 2019-2030
6.3.2 United States Anti Obesity Drugs Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Anti Obesity Drugs Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Anti Obesity Drugs Sales Value, 2019-2030
6.4.2 Europe Anti Obesity Drugs Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Anti Obesity Drugs Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Anti Obesity Drugs Sales Value, 2019-2030
6.5.2 China Anti Obesity Drugs Sales Value by Type (%), 2023 VS 2030
6.5.3 China Anti Obesity Drugs Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Anti Obesity Drugs Sales Value, 2019-2030
6.6.2 Japan Anti Obesity Drugs Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Anti Obesity Drugs Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Anti Obesity Drugs Sales Value, 2019-2030
6.7.2 South Korea Anti Obesity Drugs Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Anti Obesity Drugs Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Anti Obesity Drugs Sales Value, 2019-2030
6.8.2 Southeast Asia Anti Obesity Drugs Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Anti Obesity Drugs Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Anti Obesity Drugs Sales Value, 2019-2030
6.9.2 India Anti Obesity Drugs Sales Value by Type (%), 2023 VS 2030
6.9.3 India Anti Obesity Drugs Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Pfizer
7.1.1 Pfizer Company Information
7.1.2 Pfizer Introduction and Business Overview
7.1.3 Pfizer Anti Obesity Drugs Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Pfizer Anti Obesity Drugs Product Offerings
7.1.5 Pfizer Recent Development
7.2 Merck
7.2.1 Merck Company Information
7.2.2 Merck Introduction and Business Overview
7.2.3 Merck Anti Obesity Drugs Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Merck Anti Obesity Drugs Product Offerings
7.2.5 Merck Recent Development
7.3 Roche
7.3.1 Roche Company Information
7.3.2 Roche Introduction and Business Overview
7.3.3 Roche Anti Obesity Drugs Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Roche Anti Obesity Drugs Product Offerings
7.3.5 Roche Recent Development
7.4 GlaxoSmithKline
7.4.1 GlaxoSmithKline Company Information
7.4.2 GlaxoSmithKline Introduction and Business Overview
7.4.3 GlaxoSmithKline Anti Obesity Drugs Sales, Revenue and Gross Margin (2019-2024)
7.4.4 GlaxoSmithKline Anti Obesity Drugs Product Offerings
7.4.5 GlaxoSmithKline Recent Development
7.5 AstraZeneca
7.5.1 AstraZeneca Company Information
7.5.2 AstraZeneca Introduction and Business Overview
7.5.3 AstraZeneca Anti Obesity Drugs Sales, Revenue and Gross Margin (2019-2024)
7.5.4 AstraZeneca Anti Obesity Drugs Product Offerings
7.5.5 AstraZeneca Recent Development
7.6 Boehringer Ingelheim
7.6.1 Boehringer Ingelheim Company Information
7.6.2 Boehringer Ingelheim Introduction and Business Overview
7.6.3 Boehringer Ingelheim Anti Obesity Drugs Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Boehringer Ingelheim Anti Obesity Drugs Product Offerings
7.6.5 Boehringer Ingelheim Recent Development
7.7 Novo Nordisk
7.7.1 Novo Nordisk Company Information
7.7.2 Novo Nordisk Introduction and Business Overview
7.7.3 Novo Nordisk Anti Obesity Drugs Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Novo Nordisk Anti Obesity Drugs Product Offerings
7.7.5 Novo Nordisk Recent Development
7.8 Eisai
7.8.1 Eisai Company Information
7.8.2 Eisai Introduction and Business Overview
7.8.3 Eisai Anti Obesity Drugs Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Eisai Anti Obesity Drugs Product Offerings
7.8.5 Eisai Recent Development
7.9 Norgine
7.9.1 Norgine Company Information
7.9.2 Norgine Introduction and Business Overview
7.9.3 Norgine Anti Obesity Drugs Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Norgine Anti Obesity Drugs Product Offerings
7.9.5 Norgine Recent Development
7.10 Arena Pharmaceuticals
7.10.1 Arena Pharmaceuticals Company Information
7.10.2 Arena Pharmaceuticals Introduction and Business Overview
7.10.3 Arena Pharmaceuticals Anti Obesity Drugs Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Arena Pharmaceuticals Anti Obesity Drugs Product Offerings
7.10.5 Arena Pharmaceuticals Recent Development
7.11 Orexigen Therapeutics
7.11.1 Orexigen Therapeutics Company Information
7.11.2 Orexigen Therapeutics Introduction and Business Overview
7.11.3 Orexigen Therapeutics Anti Obesity Drugs Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Orexigen Therapeutics Anti Obesity Drugs Product Offerings
7.11.5 Orexigen Therapeutics Recent Development
7.12 Vivus
7.12.1 Vivus Company Information
7.12.2 Vivus Introduction and Business Overview
7.12.3 Vivus Anti Obesity Drugs Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Vivus Anti Obesity Drugs Product Offerings
7.12.5 Vivus Recent Development
7.13 Alizyme
7.13.1 Alizyme Company Information
7.13.2 Alizyme Introduction and Business Overview
7.13.3 Alizyme Anti Obesity Drugs Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Alizyme Anti Obesity Drugs Product Offerings
7.13.5 Alizyme Recent Development
7.14 Rhythm Pharmaceuticals
7.14.1 Rhythm Pharmaceuticals Company Information
7.14.2 Rhythm Pharmaceuticals Introduction and Business Overview
7.14.3 Rhythm Pharmaceuticals Anti Obesity Drugs Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Rhythm Pharmaceuticals Anti Obesity Drugs Product Offerings
7.14.5 Rhythm Pharmaceuticals Recent Development
7.15 Shionogi
7.15.1 Shionogi Company Information
7.15.2 Shionogi Introduction and Business Overview
7.15.3 Shionogi Anti Obesity Drugs Sales, Revenue and Gross Margin (2019-2024)
7.15.4 Shionogi Anti Obesity Drugs Product Offerings
7.15.5 Shionogi Recent Development
7.16 Zafgan
7.16.1 Zafgan Company Information
7.16.2 Zafgan Introduction and Business Overview
7.16.3 Zafgan Anti Obesity Drugs Sales, Revenue and Gross Margin (2019-2024)
7.16.4 Zafgan Anti Obesity Drugs Product Offerings
7.16.5 Zafgan Recent Development
8 Industry Chain Analysis
8.1 Anti Obesity Drugs Industrial Chain
8.2 Anti Obesity Drugs Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Anti Obesity Drugs Sales Model
8.5.2 Sales Channel
8.5.3 Anti Obesity Drugs Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Anti Obesity Drugs Market Trends
Table 2. Anti Obesity Drugs Market Drivers & Opportunity
Table 3. Anti Obesity Drugs Market Challenges
Table 4. Anti Obesity Drugs Market Restraints
Table 5. Global Anti Obesity Drugs Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Anti Obesity Drugs Revenue Market Share by Company (2019-2024)
Table 7. Global Anti Obesity Drugs Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Anti Obesity Drugs Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Anti Obesity Drugs Price by Company (2019-2024) & (USD/Units)
Table 10. Key Manufacturers Anti Obesity Drugs Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Anti Obesity Drugs Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Anti Obesity Drugs
Table 13. Global Anti Obesity Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti Obesity Drugs as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Anti Obesity Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Anti Obesity Drugs Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Anti Obesity Drugs Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Anti Obesity Drugs Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Anti Obesity Drugs Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Anti Obesity Drugs Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Anti Obesity Drugs Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Anti Obesity Drugs Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Anti Obesity Drugs Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Anti Obesity Drugs Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Anti Obesity Drugs Price by Type (2019-2024) & (USD/Units)
Table 27. Global Anti Obesity Drugs Price by Type (2025-2030) & (USD/Units)
Table 28. Global Anti Obesity Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Anti Obesity Drugs Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Anti Obesity Drugs Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Anti Obesity Drugs Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Anti Obesity Drugs Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Anti Obesity Drugs Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Anti Obesity Drugs Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Anti Obesity Drugs Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Anti Obesity Drugs Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Anti Obesity Drugs Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Anti Obesity Drugs Price by Application (2019-2024) & (USD/Units)
Table 39. Global Anti Obesity Drugs Price by Application (2025-2030) & (USD/Units)
Table 40. Global Anti Obesity Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Anti Obesity Drugs Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Anti Obesity Drugs Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Anti Obesity Drugs Sales Value by Region (2019-2024) & (%)
Table 44. Global Anti Obesity Drugs Sales Value by Region (2025-2030) & (%)
Table 45. Global Anti Obesity Drugs Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Anti Obesity Drugs Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Anti Obesity Drugs Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Anti Obesity Drugs Sales Volume by Region (2019-2024) & (%)
Table 49. Global Anti Obesity Drugs Sales Volume by Region (2025-2030) & (%)
Table 50. Global Anti Obesity Drugs Average Price by Region (2019-2024) & (USD/Units)
Table 51. Global Anti Obesity Drugs Average Price by Region (2025-2030) & (USD/Units)
Table 52. Key Countries/Regions Anti Obesity Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Anti Obesity Drugs Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Anti Obesity Drugs Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Anti Obesity Drugs Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Anti Obesity Drugs Sales Volume, (2025-2030) & (K Units)
Table 57. Pfizer Company Information
Table 58. Pfizer Introduction and Business Overview
Table 59. Pfizer Anti Obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2019-2024)
Table 60. Pfizer Anti Obesity Drugs Product Offerings
Table 61. Pfizer Recent Development
Table 62. Merck Company Information
Table 63. Merck Introduction and Business Overview
Table 64. Merck Anti Obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2019-2024)
Table 65. Merck Anti Obesity Drugs Product Offerings
Table 66. Merck Recent Development
Table 67. Roche Company Information
Table 68. Roche Introduction and Business Overview
Table 69. Roche Anti Obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2019-2024)
Table 70. Roche Anti Obesity Drugs Product Offerings
Table 71. Roche Recent Development
Table 72. GlaxoSmithKline Company Information
Table 73. GlaxoSmithKline Introduction and Business Overview
Table 74. GlaxoSmithKline Anti Obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2019-2024)
Table 75. GlaxoSmithKline Anti Obesity Drugs Product Offerings
Table 76. GlaxoSmithKline Recent Development
Table 77. AstraZeneca Company Information
Table 78. AstraZeneca Introduction and Business Overview
Table 79. AstraZeneca Anti Obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2019-2024)
Table 80. AstraZeneca Anti Obesity Drugs Product Offerings
Table 81. AstraZeneca Recent Development
Table 82. Boehringer Ingelheim Company Information
Table 83. Boehringer Ingelheim Introduction and Business Overview
Table 84. Boehringer Ingelheim Anti Obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2019-2024)
Table 85. Boehringer Ingelheim Anti Obesity Drugs Product Offerings
Table 86. Boehringer Ingelheim Recent Development
Table 87. Novo Nordisk Company Information
Table 88. Novo Nordisk Introduction and Business Overview
Table 89. Novo Nordisk Anti Obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2019-2024)
Table 90. Novo Nordisk Anti Obesity Drugs Product Offerings
Table 91. Novo Nordisk Recent Development
Table 92. Eisai Company Information
Table 93. Eisai Introduction and Business Overview
Table 94. Eisai Anti Obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2019-2024)
Table 95. Eisai Anti Obesity Drugs Product Offerings
Table 96. Eisai Recent Development
Table 97. Norgine Company Information
Table 98. Norgine Introduction and Business Overview
Table 99. Norgine Anti Obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2019-2024)
Table 100. Norgine Anti Obesity Drugs Product Offerings
Table 101. Norgine Recent Development
Table 102. Arena Pharmaceuticals Company Information
Table 103. Arena Pharmaceuticals Introduction and Business Overview
Table 104. Arena Pharmaceuticals Anti Obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2019-2024)
Table 105. Arena Pharmaceuticals Anti Obesity Drugs Product Offerings
Table 106. Arena Pharmaceuticals Recent Development
Table 107. Orexigen Therapeutics Company Information
Table 108. Orexigen Therapeutics Introduction and Business Overview
Table 109. Orexigen Therapeutics Anti Obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2019-2024)
Table 110. Orexigen Therapeutics Anti Obesity Drugs Product Offerings
Table 111. Orexigen Therapeutics Recent Development
Table 112. Vivus Company Information
Table 113. Vivus Introduction and Business Overview
Table 114. Vivus Anti Obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2019-2024)
Table 115. Vivus Anti Obesity Drugs Product Offerings
Table 116. Vivus Recent Development
Table 117. Alizyme Company Information
Table 118. Alizyme Introduction and Business Overview
Table 119. Alizyme Anti Obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2019-2024)
Table 120. Alizyme Anti Obesity Drugs Product Offerings
Table 121. Alizyme Recent Development
Table 122. Rhythm Pharmaceuticals Company Information
Table 123. Rhythm Pharmaceuticals Introduction and Business Overview
Table 124. Rhythm Pharmaceuticals Anti Obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2019-2024)
Table 125. Rhythm Pharmaceuticals Anti Obesity Drugs Product Offerings
Table 126. Rhythm Pharmaceuticals Recent Development
Table 127. Shionogi Company Information
Table 128. Shionogi Introduction and Business Overview
Table 129. Shionogi Anti Obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2019-2024)
Table 130. Shionogi Anti Obesity Drugs Product Offerings
Table 131. Shionogi Recent Development
Table 132. Zafgan Company Information
Table 133. Zafgan Introduction and Business Overview
Table 134. Zafgan Anti Obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Units) and Gross Margin (2019-2024)
Table 135. Zafgan Anti Obesity Drugs Product Offerings
Table 136. Zafgan Recent Development
Table 137. Key Raw Materials Lists
Table 138. Raw Materials Key Suppliers Lists
Table 139. Anti Obesity Drugs Downstream Customers
Table 140. Anti Obesity Drugs Distributors List
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Anti Obesity Drugs Product Picture
Figure 2. Global Anti Obesity Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Anti Obesity Drugs Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Anti Obesity Drugs Sales Volume (2019-2030) & (K Units)
Figure 5. Global Anti Obesity Drugs Sales Price (2019-2030) & (USD/Units)
Figure 6. Anti Obesity Drugs Report Years Considered
Figure 7. Global Anti Obesity Drugs Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Anti Obesity Drugs Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Anti Obesity Drugs Revenue in 2023
Figure 10. Anti Obesity Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Oral Medicine Picture
Figure 12. Diet Patch Picture
Figure 13. Other Picture
Figure 14. Global Anti Obesity Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 15. Global Anti Obesity Drugs Sales Value Market Share by Type, 2023 & 2030
Figure 16. Global Anti Obesity Drugs Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 17. Global Anti Obesity Drugs Sales Volume Market Share by Type, 2023 & 2030
Figure 18. Global Anti Obesity Drugs Price by Type (2019-2030) & (USD/Units)
Figure 19. Product Picture of Men
Figure 20. Product Picture of Women
Figure 21. Global Anti Obesity Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 22. Global Anti Obesity Drugs Sales Value Market Share by Application, 2023 & 2030
Figure 23. Global Anti Obesity Drugs Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 24. Global Anti Obesity Drugs Sales Volume Market Share by Application, 2023 & 2030
Figure 25. Global Anti Obesity Drugs Price by Application (2019-2030) & (USD/Units)
Figure 26. North America Anti Obesity Drugs Sales Value (2019-2030) & (US$ Million)
Figure 27. North America Anti Obesity Drugs Sales Value by Country (%), 2023 VS 2030
Figure 28. Europe Anti Obesity Drugs Sales Value (2019-2030) & (US$ Million)
Figure 29. Europe Anti Obesity Drugs Sales Value by Country (%), 2023 VS 2030
Figure 30. Asia Pacific Anti Obesity Drugs Sales Value (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Anti Obesity Drugs Sales Value by Country (%), 2023 VS 2030
Figure 32. South America Anti Obesity Drugs Sales Value (2019-2030) & (US$ Million)
Figure 33. South America Anti Obesity Drugs Sales Value by Country (%), 2023 VS 2030
Figure 34. Middle East & Africa Anti Obesity Drugs Sales Value (2019-2030) & (US$ Million)
Figure 35. Middle East & Africa Anti Obesity Drugs Sales Value by Country (%), 2023 VS 2030
Figure 36. Key Countries/Regions Anti Obesity Drugs Sales Value (%), (2019-2030)
Figure 37. Key Countries/Regions Anti Obesity Drugs Sales Volume (%), (2019-2030)
Figure 38. United States Anti Obesity Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 39. United States Anti Obesity Drugs Sales Value by Type (%), 2023 VS 2030
Figure 40. United States Anti Obesity Drugs Sales Value by Application (%), 2023 VS 2030
Figure 41. Europe Anti Obesity Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 42. Europe Anti Obesity Drugs Sales Value by Type (%), 2023 VS 2030
Figure 43. Europe Anti Obesity Drugs Sales Value by Application (%), 2023 VS 2030
Figure 44. China Anti Obesity Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 45. China Anti Obesity Drugs Sales Value by Type (%), 2023 VS 2030
Figure 46. China Anti Obesity Drugs Sales Value by Application (%), 2023 VS 2030
Figure 47. Japan Anti Obesity Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 48. Japan Anti Obesity Drugs Sales Value by Type (%), 2023 VS 2030
Figure 49. Japan Anti Obesity Drugs Sales Value by Application (%), 2023 VS 2030
Figure 50. South Korea Anti Obesity Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 51. South Korea Anti Obesity Drugs Sales Value by Type (%), 2023 VS 2030
Figure 52. South Korea Anti Obesity Drugs Sales Value by Application (%), 2023 VS 2030
Figure 53. Southeast Asia Anti Obesity Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 54. Southeast Asia Anti Obesity Drugs Sales Value by Type (%), 2023 VS 2030
Figure 55. Southeast Asia Anti Obesity Drugs Sales Value by Application (%), 2023 VS 2030
Figure 56. India Anti Obesity Drugs Sales Value, (2019-2030) & (US$ Million)
Figure 57. India Anti Obesity Drugs Sales Value by Type (%), 2023 VS 2030
Figure 58. India Anti Obesity Drugs Sales Value by Application (%), 2023 VS 2030
Figure 59. Anti Obesity Drugs Industrial Chain
Figure 60. Anti Obesity Drugs Manufacturing Cost Structure
Figure 61. Channels of Distribution (Direct Sales, and Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
